Exponent, Inc. (EXPO)
NASDAQ: EXPO · Real-Time Price · USD
57.77
+0.71 (1.24%)
At close: May 22, 2026, 4:00 PM EDT
58.00
+0.23 (0.40%)
After-hours: May 22, 2026, 7:38 PM EDT

Revenue by Geography

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Apr '26 Jan '26 Jan '25 Dec '23 Dec '22 Dec '21 Jan '21 Jan '20 Dec '18 Dec '17 Dec '16 Jan '16 Jan '15 Jan '14 Dec '12
United States Revenue
-520.59M493.07M
United States Revenue Growth
-5.58%4.89%
Foreign Countries Revenue
-61.42M65.45M
Foreign Countries Revenue Growth
--6.15%-1.86%
Revenue (Total)
602.81M582.01M558.51M
Revenue (Total) Growth
3.57%4.21%4.05%

Revenue

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Apr '26 Jan '26 Jan '25 Dec '23 Dec '22 Dec '21 Jan '21 Jan '20 Dec '18 Dec '17 Dec '16 Jan '16 Jan '15 Jan '14 Dec '12
Engineering and Other Scientific Revenue
513.17M493.89M469.54M
Engineering and Other Scientific Revenue Growth
3.90%5.19%5.07%
Environmental and Health Revenue
89.64M88.12M88.97M
Environmental and Health Revenue Growth
1.72%-0.95%-1.01%
Revenue (Total)
602.81M582.01M558.51M
Revenue (Total) Growth
3.57%4.21%4.05%

EBIT

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Apr '26 Jan '26 Jan '25 Dec '23 Dec '22 Dec '21 Jan '21 Jan '20 Dec '18 Dec '17 Dec '16 Jan '16 Jan '15 Jan '14 Dec '12
Engineering and Other Scientific Operating Income
178.93M173.63M164.88M
Engineering and Other Scientific Operating Income Growth
3.05%5.30%7.12%
Environmental and Health Operating Income
30.25M30.56M30.00M
Environmental and Health Operating Income Growth
-1.02%1.88%5.50%
Corporate Operating Income
-92.44M-84.40M-75.32M
Operating Income (Total)
116.73M119.79M119.56M
Operating Income (Total) Growth
-2.55%0.19%7.40%

Capital Expenditures

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Apr '26 Jan '26 Jan '25 Dec '23 Dec '22 Dec '21 Jan '21 Jan '20 Dec '18 Dec '17 Dec '16 Jan '16 Jan '15 Jan '14 Dec '12
Engineering and Other Scientific Capital Expenditures
5.50M5.34M3.26M
Engineering and Other Scientific Capital Expenditures Growth
2.94%63.98%-16.38%
Environmental and Health Capital Expenditures
215.00K238.00K77.00K
Environmental and Health Capital Expenditures Growth
-9.66%209.09%-54.71%
Corporate Capital Expenditures
4.50M3.48M4.04M
Corporate Capital Expenditures Growth
29.41%-13.98%-72.36%

Key Performance Indicators

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Apr '26 Jan '26 Jan '25 Dec '23 Dec '22 Dec '21 Jan '21 Jan '20 Dec '18 Dec '17 Dec '16 Jan '16 Jan '15 Jan '14 Dec '12
Technical Full-Time Equivalent Employees
1.01K973.00967.00
Technical Full-Time Equivalent Employees Growth
4.11%0.62%-7.73%
Updated May 8, 2026. Data Source: Fiscal.ai.